Literature DB >> 32697172

COVID-19 and persons with substance use disorders: Inequities and mitigation strategies.

Osnat C Melamed1,2, Tanya S Hauck1,3, Leslie Buckley1,3, Peter Selby1,2,3,4, Benoit H Mulsant1,3.   

Abstract

The COVID-19 pandemic disproportionately disrupts the daily lives of marginalized populations. Persons with substance use disorders are a particularly vulnerable population because of their unique social and health care needs. They face significant harm from both the pandemic itself and its social and economic consequences, including marginalization in health care and social systems. Hence, we discuss: (1) why persons with substance use disorders are at increased risk for infection with COVID-19 and a severe illness course; (2) anticipated adverse consequences of COVID-19 in persons with substance use disorders; (3) challenges to health care delivery and substance use treatment programs during and after the COVID-19 pandemic; and (4) the potential impact on clinical research in substance use disorders. We offer recommendations for clinical, public health, and social policies to mitigate these challenges and to prevent negative outcomes.

Entities:  

Keywords:  COVID-19; addiction; alcohol; cannabis; clinical care; clinical research; cocaine; opioids; pandemic; substance use disorders; tobacco

Mesh:

Year:  2020        PMID: 32697172     DOI: 10.1080/08897077.2020.1784363

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  29 in total

1.  Ambulance Calls for Substance-Related Issues Before and After COVID-19.

Authors:  Scott G Weiner; Rebecca E Cash; Michelle Hendricks; Sanae El Ibrahimi; Olesya Baker; Raghu R Seethala; Gregory Peters; Scott A Goldberg
Journal:  Prehosp Emerg Care       Date:  2020-12-15       Impact factor: 3.077

2.  Collecting Data During the COVID-19 Pandemic: Lessons From an In-Person Survey of People Who Use Opioids.

Authors:  Lauren Jessell; Izza Zaidi; Leonardo Dominguez-Gomez; Alex Harocopos
Journal:  Public Health Rep       Date:  2022-01-13       Impact factor: 2.792

3.  Supporting the Health of HIV-Positive People Who Inject Drugs During COVID-19 and Beyond: Lessons for the United States from St. Petersburg, Russia.

Authors:  Jennifer J Carroll; Sarah L Rossi; Marina V Vetrova; Tetiana Kiriazova; Karsten Lunze
Journal:  Am J Public Health       Date:  2022-04       Impact factor: 9.308

Review 4.  Virtual recruitment and participant engagement for substance use research during a pandemic.

Authors:  Carolin C Hoeflich; Anna Wang; Ayodeji Otufowora; Linda B Cottler; Catherine W Striley
Journal:  Curr Opin Psychiatry       Date:  2022-06-09       Impact factor: 4.787

5.  Virtual Community Engagement Studio (V-CES): Engaging Mothers With Mental Health and Substance Use Conditions in Research.

Authors:  Yaara Zisman-Ilani; Jennifer Buell; Shayna Mazel; Shannon Hennig; Joanne Nicholson
Journal:  Front Psychiatry       Date:  2022-06-15       Impact factor: 5.435

6.  Mixed methods prospective findings of the initial effects of the U.S. COVID-19 pandemic on individuals in recovery from substance use disorder.

Authors:  Katherine Shircliff; Melissa Liu; Christiana Prestigiacomo; Melissa Fry; Kevin Ladd; Misty Kannapel Gilbert; Mary Jo Rattermann; Melissa A Cyders
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

7.  A Descriptive Comparison of Substance Use Services in Recovery and Isolation Sites for People Experiencing Homelessness During the COVID-19 Pandemic, Boston and Toronto.

Authors:  Miriam T H Harris; Samantha Young; Joshua Barocas; Ahmed M Bayoumi; Alexander Caudarella; Gab Laurence; Mary Tomanovich; Miriam Komaromy
Journal:  Public Health Rep       Date:  2021-07-16       Impact factor: 3.117

8.  Common themes in early state policy responses to substance use disorder treatment during COVID-19.

Authors:  Barbara Andraka-Christou; Kathryn Bouskill; Rebecca L Haffajee; Olivia Randall-Kosich; Matthew Golan; Rachel Totaram; Adam J Gordon; Bradley D Stein
Journal:  Am J Drug Alcohol Abuse       Date:  2021-04-28       Impact factor: 3.912

9.  Decrease in prevalence but increase in frequency of non-marijuana drug use following the onset of the COVID-19 pandemic in a large cohort of young men who have sex with men and young transgender women.

Authors:  Patrick Janulis; Michael E Newcomb; Brian Mustanski
Journal:  Drug Alcohol Depend       Date:  2021-04-10       Impact factor: 4.852

10.  Evolution of the Illegal Substances Market and Substance Users' Social Situation and Health during the COVID-19 Pandemic.

Authors:  Jacques Gaume; Elodie Schmutz; Jean-Bernard Daeppen; Frank Zobel
Journal:  Int J Environ Res Public Health       Date:  2021-05-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.